Logo image of CBB.MI

CLEANBNB SPA (CBB.MI) Stock Fundamental Analysis

BIT:CBB - Euronext Milan - IT0005377277 - Common Stock - Currency: EUR

1.22  0 (0%)

Fundamental Rating

4

Taking everything into account, CBB scores 4 out of 10 in our fundamental rating. CBB was compared to 73 industry peers in the Real Estate Management & Development industry. CBB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CBB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CBB was profitable.
CBB had a positive operating cash flow in the past year.
In multiple years CBB reported negative net income over the last 5 years.
In multiple years CBB reported negative operating cash flow during the last 5 years.
CBB.MI Yearly Net Income VS EBIT VS OCF VS FCFCBB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

The Return On Assets of CBB (5.91%) is better than 93.15% of its industry peers.
CBB has a better Return On Equity (23.77%) than 97.26% of its industry peers.
CBB has a better Return On Invested Capital (13.43%) than 98.63% of its industry peers.
Industry RankSector Rank
ROA 5.91%
ROE 23.77%
ROIC 13.43%
ROA(3y)2.47%
ROA(5y)-9.14%
ROE(3y)9.47%
ROE(5y)-59.42%
ROIC(3y)N/A
ROIC(5y)N/A
CBB.MI Yearly ROA, ROE, ROICCBB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

CBB has a Profit Margin of 3.04%. This is comparable to the rest of the industry: CBB outperforms 58.90% of its industry peers.
CBB has a Operating Margin (3.37%) which is in line with its industry peers.
The Gross Margin of CBB (12.28%) is worse than 67.12% of its industry peers.
Industry RankSector Rank
OM 3.37%
PM (TTM) 3.04%
GM 12.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBB.MI Yearly Profit, Operating, Gross MarginsCBB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CBB is creating some value.
Compared to 1 year ago, CBB has about the same amount of shares outstanding.
Compared to 5 years ago, CBB has more shares outstanding
The debt/assets ratio for CBB has been reduced compared to a year ago.
CBB.MI Yearly Shares OutstandingCBB.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CBB.MI Yearly Total Debt VS Total AssetsCBB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

CBB has an Altman-Z score of 3.27. This indicates that CBB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.27, CBB belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
CBB has a debt to FCF ratio of 0.24. This is a very positive value and a sign of high solvency as it would only need 0.24 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.24, CBB belongs to the best of the industry, outperforming 98.63% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that CBB is not too dependend on debt financing.
CBB has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. CBB outperforms 84.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.24
Altman-Z 3.27
ROIC/WACC1.71
WACC7.84%
CBB.MI Yearly LT Debt VS Equity VS FCFCBB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

CBB has a Current Ratio of 1.58. This is a normal value and indicates that CBB is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.58, CBB perfoms like the industry average, outperforming 53.42% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that CBB should not have too much problems paying its short term obligations.
CBB's Quick ratio of 1.58 is fine compared to the rest of the industry. CBB outperforms 67.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
CBB.MI Yearly Current Assets VS Current LiabilitesCBB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

CBB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.29%, which is quite impressive.
The Revenue has grown by 27.10% in the past year. This is a very strong growth!
Measured over the past years, CBB shows a very strong growth in Revenue. The Revenue has been growing by 44.54% on average per year.
EPS 1Y (TTM)101.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.02%
Revenue 1Y (TTM)27.1%
Revenue growth 3Y71.04%
Revenue growth 5Y44.54%
Sales Q2Q%20.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBB.MI Yearly Revenue VS EstimatesCBB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

4. Valuation

4.1 Price/Earnings Ratio

CBB is valuated rather expensively with a Price/Earnings ratio of 20.33.
Based on the Price/Earnings ratio, CBB is valued a bit cheaper than 68.49% of the companies in the same industry.
CBB is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.33
Fwd PE N/A
CBB.MI Price Earnings VS Forward Price EarningsCBB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBB indicates a rather cheap valuation: CBB is cheaper than 97.26% of the companies listed in the same industry.
78.08% of the companies in the same industry are more expensive than CBB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.54
EV/EBITDA 2.17
CBB.MI Per share dataCBB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEANBNB SPA

BIT:CBB (7/11/2025, 7:00:00 PM)

1.22

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.52M
Analysts80
Price Target3.06 (150.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.33
Fwd PE N/A
P/S 0.6
P/FCF 8.54
P/OCF 6.87
P/B 4.66
P/tB 5.88
EV/EBITDA 2.17
EPS(TTM)0.06
EY4.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY11.71%
OCF(TTM)0.18
OCFY14.55%
SpS2.05
BVpS0.26
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.91%
ROE 23.77%
ROCE 15.76%
ROIC 13.43%
ROICexc N/A
ROICexgc N/A
OM 3.37%
PM (TTM) 3.04%
GM 12.28%
FCFM 6.97%
ROA(3y)2.47%
ROA(5y)-9.14%
ROE(3y)9.47%
ROE(5y)-59.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.24
Debt/EBITDA 0.06
Cap/Depr 71.49%
Cap/Sales 1.69%
Interest Coverage 250
Cash Conversion 150.97%
Profit Quality 229.57%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 3.27
F-Score8
WACC7.84%
ROIC/WACC1.71
Cap/Depr(3y)58.23%
Cap/Depr(5y)58.71%
Cap/Sales(3y)1.87%
Cap/Sales(5y)3.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.1%
Revenue growth 3Y71.04%
Revenue growth 5Y44.54%
Sales Q2Q%20.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y87.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y171.96%
FCF growth 3Y244.95%
FCF growth 5YN/A
OCF growth 1Y204.29%
OCF growth 3Y112.28%
OCF growth 5YN/A